The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Conditional survival (CS) for patients with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor (VEGF)-targeted therapy (TT): Results from the international mRCC database consortium.
Toni K. Choueiri
No relevant relationships to disclose
Wanling Xie
No relevant relationships to disclose
Lauren Christine Harshman
No relevant relationships to disclose
Georg A. Bjarnason
No relevant relationships to disclose
Jennifer J. Knox
No relevant relationships to disclose
Mary J. MacKenzie
No relevant relationships to disclose
Lori Wood
No relevant relationships to disclose
Ulka N. Vaishampayan
No relevant relationships to disclose
Min-Han Tan
No relevant relationships to disclose
Sun Young Rha
No relevant relationships to disclose
Frede Donskov
No relevant relationships to disclose
Neeraj Agarwal
No relevant relationships to disclose
Christian K. Kollmannsberger
No relevant relationships to disclose
Scott A. North
No relevant relationships to disclose
Brian I. Rini
No relevant relationships to disclose
Daniel Yick Chin Heng
No relevant relationships to disclose